~53 spots leftby Aug 2028

Single Session Intervention for Type 1 Diabetes

(ASSISTED Trial)

AM
Overseen ByAlexandra Monzon, PhD
Age: < 18
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: Nemours Children's Health System

Trial Summary

What is the purpose of this trial?

The goal of this clinical trial is to learn if implementing a single-session depression intervention for youth with type 1 diabetes (T1D) is feasible and acceptable to patients. can help improve mood and health outcomes. It will also learn about the initial efficacy of the intervention. The main questions it aims to answer are: 1. Is a single-session depression intervention for youth with T1D feasible to recruit and implement? 2. Is a single-session depression intervention for youth with T1D acceptable to patients (i.e., do they find it helpful)? 3. Does a single-session depression intervention for youth with T1D lead to improvements in low mood? Researchers will compare a single-session depression intervention for youth with to a education control to see if a single-session depression intervention works to improve depressive symptoms. Participants will: * Participate in a single-session depression intervention * Complete questionnaires and provide a sample for A1c at a baseline, 3-month, and 6-month visit * Complete daily questionnaires once a day for two weeks before and after the single-session depression intervention

Eligibility Criteria

This trial is for young people with Type 1 Diabetes (T1D), including those who may be experiencing low mood or depression. Participants should be willing to attend a single-session intervention, fill out questionnaires, and provide A1c samples over a period of six months.

Inclusion Criteria

I am between 11 and 18 years old.
I have been diagnosed with Type 1 Diabetes for at least 6 months.
Positive depression screening score of >5 on the PHQ-9 in the last year
See 2 more

Exclusion Criteria

Any score of 1, 2, or 3 on item 9 (indicating suicidal ideation) of the PHQ-9 in the last year.
I have a chronic illness, but it's not celiac disease, autoimmune thyroiditis, microalbuminuria, hypertension, or well-managed asthma.

Treatment Details

Interventions

  • T1D-specific depression SSI (Behavioral Intervention)
Trial OverviewThe study tests if a one-time educational session focused on depression can improve the mood and health outcomes of youths with T1D. It compares this approach against regular diabetes education to see which is more effective in reducing depressive symptoms.
Participant Groups
2Treatment groups
Experimental Treatment
Placebo Group
Group I: T1D-specific depression SSIExperimental Treatment1 Intervention
Single session depression intervention adapted for youth with T1D. The T1D-specific depression SSI will include 1) psychoeducation about depression, including how behavior shapes feelings and thoughts, 2) a values assessment, where youth will identify key areas (i.e., family relationships, friendships, school, or hobbies) from which they draw (or once drew) enjoyment and meaning, and 3) the creation of an activity action plan, wherein youth identify (from pre-generated lists) and personalize (in guided exercises) three activities to target for change.
Group II: T1D EducationPlacebo Group1 Intervention
Educational material about T1D

Find a Clinic Near You

Who Is Running the Clinical Trial?

Nemours Children's Health System

Lead Sponsor

Trials
11
Recruited
17,400+

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborator

Trials
2,513
Recruited
4,366,000+